Purchase Order 75D30118P03105

Award Date 8/29/18
Potential Completion Date 9/30/18
Potential Value $78K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portland, OR 97230, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Sedia Biosciences Corporation, a privately held medical device and diagnostics company, to provide Asante HIV-1 Rapid Recency Assays and HIV-1 LAg-Avidity EIA Avidity Kits. The $119,155.00 contract was awarded on September 3, 2020, with a completion date of April 15, 2021. These products are used in the CDC's ongoing HIV surveillance program and are only available from Sedia Biosciences Corporation....
This federal contract award is for $149,825.00 in laboratory supplies and equipment to support disease monitoring and prevention programs at the Centers for Disease Control and Prevention (CDC). The prime contractor is Sedia Biosciences Corporation, doing business as Sedia Biosciences Corp, a privately held medical device and diagnostics company that provides laboratory supplies and equipment. The award includes firm fixed price purchase orders for rapid HIV recency assay kits, laboratory...
The Centers for Disease Control and Prevention (CDC) awarded an $82,263 firm fixed price purchase order to Sedia Biosciences Corporation for laboratory supplies and equipment to support rapid recency kits. Sedia Biosciences, doing business as Sedia Biosciences Corp., will deliver the requested supplies and equipment from its location in Chamblee, Georgia to support CDC programs in Pittsburgh, Pennsylvania by December 30, 2023. No subcontractors or set aside designations were identified. The...
The Centers for Disease Control and Prevention, under the Department of Health and Human Services, awarded a $16,070 firm fixed price purchase order to Miscellaneous Foreign Awardees for HAIN LIFESCIENCE GENOTYPE LINE PROBE ASSAY KITS AND REAGENTS. Performance will take place in Germany from September 26, 2023 through October 16, 2023. The award is likely associated with CDC's infectious disease diagnostic testing and surveillance programs. No subcontractors or set aside designations were...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $33,840 firm fixed-price purchase order to Sebia, Inc., a global leader in automated electrophoresis technologies, to provide medical equipment, reagents, consumables, testing services, and maintenance support. This award is not set aside and is part of Sebia's broader contract vehicles with the Department of Veterans Affairs (VA) and Department of Defense (DoD) to deliver its specialized clinical laboratory technologies....
The Centers for Disease Control and Prevention (CDC) in Pittsburgh has awarded a $57,490.00 firm fixed-price purchase order to Seegene USA Inc. Sales Division, a foreign-owned, for-profit small disadvantaged business, for the procurement of NOVAPLEX HPV28 DETECTION KITS. The award has an ultimate completion date of May 30, 2025 and supports the CDC's public health mission related to HPV screening and prevention. This order follows previous contract awards to Seegene USA Inc. Sales Division for...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The $91,758.84 firm fixed-price purchase order is for the delivery of HIV test kits and supplies. The contract does not have a set-aside designation and has an ultimate completion date of December 31, 2021. Life Technologies Corporation, as the prime contractor, is a leading provider of biomedical research and genetic...
<p>This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Premier Medical USA Corp for the SURE STATUS HIV-1 RECENCY TEST (25 TESTS/KIT). The contract has a ceiling value of $50,450.00 and a period of performance through July 30, 2029. There is no set-aside designation associated with this contract. The place of performance is Somerset, Franklin Township, New Jersey.</p>
This firm-fixed-price $240,049.95 purchase order was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian federal agency, to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of custom TaqMan array cards, without any set-aside designation. Life Technologies has an active Indefinite Delivery Vehicle (IDV) contract with the National Institutes of Health (NIH),...
The Department of Health and Human Services Centers for Disease Control and Prevention (HHS-CDC) in Pittsburgh awarded a $19,036 purchase order to Inbios International Inc. of Seattle, Washington for INBIOS supplies and reagents. As a prime contractor, Inbios will provide laboratory materials to support HHS-CDC's disease prevention and control efforts. The firm fixed price contract runs from August 24, 2023 through September 28, 2023 at the Inbios location in Seattle. No subcontractors or set...

This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Sedia Biosciences Corporation, doing business as Sedia Biosciences Corp, for the provision of Asante HIV-1 Rapid Recency Assay kits. The $77,950.00 contract supports CDC disease surveillance and prevention initiatives, with the kits being delivered to the CDC's Pittsburgh, Pennsylvania facility. Sedia Biosciences Corp has previously received over $350,000 in CDC purchase orders for similar laboratory supplies and equipment. No set-aside designation was associated with this contract award.

Generated 4/1/25, 9:30 PM